A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

NCT05954910 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Polatuzumab Vedotin

Sponsor

Hoffmann-La Roche